It will hardly come as a surprise to most prostate cancer support group leaders and other prostate cancer advocates that there is a strong association between patient age and risk for side effects of radical prostatectomy. However, we now have a rather more sophisticated set of insight into such risks. Read the article.
Repeat biopsy before radical prostatectomy impairs early continence after surgery. However, erectile function recovery and mid‐term to long‐term continence are not affected. These data support the current trend towards active surveillance and delayed local treatment in patients with low‐ to intermediate‐risk prostate cancer. Read the article here.
A study by researchers at the UCLA Jonsson Comprehensive Cancer Center provides convincing evidence that radiation-based treatments and surgery are equally effective treatments for aggressive prostate cancer. It also suggests that a particular form of radiation therapy, consisting of external radiation followed by brachytherapy (a type of radiation treatment in which a radioactive source is placed into the tumor directly) provides the best chance of preventing metastatic disease. Read the article here.
The Ontario Health Technology Advisory Committee (OHTAC) has recommended against publicly funding robotic surgery for prostate cancer. OHTAC determined there was not enough evidence that the minimally invasive procedure is better than traditional open surgery to justify the increased price of $6,000 per patient. Read article 1 here. Read article 2 here.
In this video, shared by Continence Foundation of Australia, listen to Specialist Continence & Women’s Health Physiotherapist, Shan Morrison, as she discusses urinary incontinence in men after prostate cancer surgery. Dr. Morrison also talks about pelvic floor exercises and how these can help men in their recovery. Watch the video here.